Dr. Mustafa Ahmed, MD
Claim this profileUniversity of Alabama at Birmingham
About Mustafa Ahmed, MD
Education:
- Graduated from Victoria University, Manchester, England.
- Completed Internship at Manchester Royal Infirmary.
- Residency and Fellowship at Queens Medical Center and University of Alabama at Birmingham.
Experience:
- Board Certified in Cardiovascular Disease since 2014.
- Specializes in Cardiology and Interventional Cardiology, focusing on minimally invasive procedures like TAVR and Mitraclip.
- Utilizes 3D imaging for complex structural heart disease evaluation and treatment.
- Holds a Research Fellowship in Interventional Cardiology at UAB and has authored over 90 publications.
Affiliated Hospitals
University Of Alabama At Birmingham
University Of Alabama At Birmingham (UAB) Hospital
Clinical Trials Mustafa Ahmed, MD is currently running
TMVR
for Mitral Valve Regurgitation
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Recruiting
1 award
N/A
AccuCinch System
for Heart Failure
This trial is testing a new device called the AccuCinch Ventricular Restoration System in patients with a specific type of heart failure. The device helps the heart pump blood more effectively by supporting and reshaping its lower chamber. The study aims to see if this device, combined with standard medical treatment, is safe and effective. The CorCap Cardiac Support Device (CSD) is a predecessor that has shown safety and effectiveness in improving left ventricular structure and function in heart failure patients.
Recruiting
1 award
N/A
9 criteria
More about Mustafa Ahmed, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Mustafa Ahmed, MD has experience with
- ACURATE Neo2™ Transfemoral TAVR System
- Medtronic CoreValve TAVR System
- Edwards SAPIEN 3 TAVR System
- ACURATE Prime™ Transfemoral TAVR System XL
- AGENT DCB
- PTCA Balloon Catheter
Breakdown of trials Mustafa Ahmed, MD has run
Mitral Regurgitation
Mitral Valve Regurgitation
Cardiovascular Disease
Heart Failure
Aortic Stenosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mustafa Ahmed, MD specialize in?
Mustafa Ahmed, MD focuses on Mitral Regurgitation and Mitral Valve Regurgitation. In particular, much of their work with Mitral Regurgitation has involved Stage III patients, or patients who are undergoing treatment.
Is Mustafa Ahmed, MD currently recruiting for clinical trials?
Yes, Mustafa Ahmed, MD is currently recruiting for 5 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Mustafa Ahmed, MD has studied deeply?
Yes, Mustafa Ahmed, MD has studied treatments such as ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System.
What is the best way to schedule an appointment with Mustafa Ahmed, MD?
Apply for one of the trials that Mustafa Ahmed, MD is conducting.
What is the office address of Mustafa Ahmed, MD?
The office of Mustafa Ahmed, MD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35294 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.